Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study


ARTAÇ M., COŞKUN H. Ş. , Korkmaz L., Kocer M. , Turhal N. S. , ENGİN H., ...More

CLINICAL GENITOURINARY CANCER, vol.14, no.4, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2016
  • Doi Number: 10.1016/j.clgc.2016.04.021
  • Title of Journal : CLINICAL GENITOURINARY CANCER

Abstract

Survival outcomes of interferon-alfa and tyrosine kinase inhibitors for 104 cases of metastatic renal cell carcinoma were included in this study. First-line interferon-alfa treatment before tyrosine kinase inhibitors had an additive survival affect.